DepoMed (DEPO) Misses Q1 EPS by 14c; Guides FY15 Sales Above Views
Tweet
Share
E-mailGet Alerts DEPO Hot Sheet
Price: $7.30 --0%
Financial Fact:
Income (loss) from operations: 1.26M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Income (loss) from operations: 1.26M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
DepoMed (NASDAQ: DEPO) reported Q1 EPS of ($0.13), $0.14 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $31.7 million versus the consensus estimate of $33.8 million.
DepoMed sees FY2015 revenue of $310-335 million, versus the consensus of $305.02 million.
For earnings history and earnings-related data on DepoMed (DEPO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
